Does the Instruction Leaflet for Omeprazole Enteric-coated Tablets Clearly Outline the Recommended Dosage?

Update Date: 2024-09-11 Source: Network

Instructions for Omeprazole Enteric-coated Tablets

Most people fail to thoroughly read the medication instructions when taking common drugs, and even for specialized medications treating specific conditions, the dosage prescribed by doctors may differ from that stated in the instructions, as they tailor the dosage based on the patient's condition and medication combinations.

Omeprazole Enteric-coated Tablets are used to treat digestive system disorders. Does the instruction leaflet for Omeprazole Enteric-coated Tablets specify the dosage?

Yes, the instruction leaflet for Omeprazole Enteric-coated Tablets does specify the dosage.

I. Drug Name

Omeprazole Enteric-coated Tablets

II. Ingredients

Main Ingredient: Omeprazole.
Chemical Name: 5-Methoxy-2-{[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]-sulfinyl}-1H-benzimidazole;
Molecular Formula: C17H19N3O3S;
Molecular Weight: 345.41.

III. Indications

Peptic Ulcer

IV. Packaging Specification

20mg

V. Dosage and Administration

Oral administration. Do not chew.
1. Peptic Ulcer: 20mg (1 tablet) per dose. 1 to 2 times daily. Take in the morning or once in the morning and once in the evening. The treatment duration for gastric ulcer is usually 4 to 8 weeks, and 2 to 4 weeks for duodenal ulcer.
2. Reflux Esophagitis: 20 to 60mg (1 to 3 tablets) per dose. 1 to 2 times daily. Take in the morning or once in the morning and once in the evening. The treatment duration is usually 4 to 8 weeks.
3. Zollinger-Ellison Syndrome: 60mg (3 tablets) per dose, once daily. The total daily dosage can be adjusted to 20 to 120mg (1 to 6 tablets) based on the patient's condition. If the total daily dosage exceeds 80mg (4 tablets), it should be divided into two doses.

VI. Adverse Reactions

This medication is well-tolerated. Common adverse reactions include diarrhea, headache, nausea, abdominal pain, flatulence, and constipation. Occasionally, elevations in serum aminotransferase (ALT, AST), rash, dizziness, drowsiness, and insomnia may occur. These reactions are generally mild, self-limiting, and not dose-related. No serious adverse reactions have been observed with long-term use, but gastric mucosal cell hyperplasia and atrophic gastritis may occur in some cases.

VII. Contraindications

This medication is contraindicated for individuals with hypersensitivity to it, those with severe renal insufficiency, and infants and young children.

VIII. Precautions

1. When treating gastric ulcer, the possibility of ulcerous gastric cancer should be ruled out first, as treatment with this medication may alleviate symptoms, thereby delaying proper diagnosis and treatment.
2. Use with caution in patients with impaired liver or renal function.
3. This is an enteric-coated capsule. Avoid chewing it to prevent premature release of the medication in the stomach, which may affect its efficacy.